STOCK TITAN

[SCHEDULE 13G/A] Calamos Strategic Total Return Fund SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

The filing is an amendment to a Schedule 13G reporting that a group of related Apollo entities and Athene Annuity and Life Company collectively hold 1,920,000 Series F Mandatory Redeemable Preferred Shares of Calamos Strategic Total Return Fund. That holding represents 48.0% of the 4,000,000 MRPS outstanding (per the issuer's certified shareholder report dated April 30, 2025). No reporting person claims sole voting or dispositive power; each reports zero sole power and shared voting and dispositive power over 1,920,000 shares. The filing states the securities were acquired and are held in the ordinary course of business and not to change or influence control of the issuer.

La comunicazione è una modifica a un Schedule 13G che segnala come un gruppo di entità correlate di Apollo e Athene Annuity and Life Company detengano collettivamente 1.920.000 azioni preferenziali Serie F obbligatoriamente rimborsabili di Calamos Strategic Total Return Fund. Tale partecipazione rappresenta il 48,0% delle 4.000.000 MRPS in circolazione (secondo il rapporto certificato degli azionisti dell’emittente del 30 aprile 2025). Nessun soggetto dichiara poteri di voto o dispositivi in via esclusiva; ciascuno riporta zero poteri esclusivi e potere di voto e dispositivo condiviso su 1.920.000 azioni. La comunicazione afferma che i titoli sono stati acquisiti e sono detenuti nell’ordinario svolgimento dell’attività e non per cambiare o influenzare il controllo dell’emittente.

La presentación es una enmienda a un Schedule 13G que informa que un grupo de entidades relacionadas de Apollo y Athene Annuity and Life Company poseen colectivamente 1.920.000 acciones preferentes Serie F redimibles obligatoriamente de Calamos Strategic Total Return Fund. Esa participación representa el 48,0% de las 4.000.000 MRPS en circulación (según el informe certificado de accionistas del emisor de fecha 30 de abril de 2025). Ninguna persona informante reclama poder de voto o dispositivo exclusivo; cada una declara cero poder exclusivo y poder de voto y dispositivo compartido sobre 1.920.000 acciones. La presentación indica que los valores fueron adquiridos y se mantienen en el curso ordinario del negocio y no para cambiar o influir en el control del emisor.

이번 제출 서류는 Schedule 13G의 수정서로, 관련된 Apollo 계열사 그룹과 Athene Annuity and Life Company가 합쳐서 Calamos Strategic Total Return Fund의 1,920,000주 Series F 강제상환 우선주를 보유하고 있음을 보고합니다. 해당 보유분은 발행사 인증 주주보고서(2025년 4월 30일 기준)에 따른 유통 중인 4,000,000 MRPS의 48.0%에 해당합니다. 어떠한 보고인도 단독 의결권이나 처분권을 주장하지 않으며, 각 보고인은 단독 권한은 0이고 1,920,000주에 대해 공동 의결권 및 처분권을 보유한다고 보고합니다. 제출서류는 이 증권들이 영업 과정에서 취득·보유된 것이며 발행사의 지배권을 변경하거나 영향 미치려는 목적이 아님을 명시합니다.

Le dépôt est un amendement à un Schedule 13G déclarant qu’un groupe d’entités liées d’Apollo et Athene Annuity and Life Company détiennent collectivement 1 920 000 actions privilégiées Série F à rachat obligatoire du Calamos Strategic Total Return Fund. Cette participation représente 48,0 % des 4 000 000 MRPS en circulation (d’après le rapport certifié des actionnaires de l’émetteur en date du 30 avril 2025). Aucun déclarant ne revendique un pouvoir de vote ou de disposition exclusif ; chacun déclare zéro pouvoir exclusif et pouvoir de vote et de disposition partagé sur 1 920 000 actions. Le dépôt indique que les titres ont été acquis et sont détenus dans le cours normal des affaires et non dans le but de changer ou d’influencer le contrôle de l’émetteur.

Die Einreichung ist eine Änderung zu einem Schedule 13G, die meldet, dass eine Gruppe zusammengehöriger Apollo-Gesellschaften und die Athene Annuity and Life Company zusammen 1.920.000 Series F Mandatory Redeemable Preferred Shares des Calamos Strategic Total Return Fund halten. Diese Beteiligung entspricht 48,0% der 4.000.000 ausstehenden MRPS (laut dem zertifizierten Aktionärsbericht des Emittenten vom 30. April 2025). Keine meldende Person beansprucht alleiniges Stimm- oder Verfügungsrecht; jede gibt keine alleinigen Rechte und gemeinsame Stimm- und Verfügungsrechte für 1.920.000 Aktien an. In der Einreichung heißt es, die Wertpapiere seien im ordentlichen Geschäftsbetrieb erworben und gehalten worden und dienten nicht der Änderung oder Beeinflussung der Kontrolle über den Emittenten.

Positive
  • Material stake disclosed: Reporting Persons collectively hold 1,920,000 MRPS, representing 48.0% of the class
  • Clear ownership breakdown: Each reporting person reports shared voting and dispositive power with zero sole power
  • Compliance and certification: Filing includes required entity identifications, addresses and signed certifications dated 08/14/2025
Negative
  • None.

Insights

TL;DR A coordinated group of Apollo entities and Athene own a near-majority 48% stake in the Series F preferreds, creating material influence potential.

The Schedule 13G/A shows a large, concentrated position: 1,920,000 MRPS representing 48% of the class. All reporting persons disclaim sole ownership and report shared voting and dispositive power only. For investors, concentrated preferred-holdings at this scale can affect liquidity and negotiation dynamics for the preferred class, though the filing expressly disclaims acquisition for control. The ownership percentage is calculated from 4,000,000 shares outstanding as of April 30, 2025, per the issuer's certified report.

TL;DR A related-party group holds substantial preferred-class power, which is material for governance and creditor-preference considerations.

The report lists multiple interrelated entities (investment adviser, general partners, holding companies) that collectively report shared voting and dispositive power over 1,920,000 MRPS. While the signatories disclaim a purpose to change control and indicate ordinary-course holdings, the concentration across related entities is material to governance and potential future transactions involving the preferred class. The filing includes addresses and entity classifications consistent with standard disclosure practice.

La comunicazione è una modifica a un Schedule 13G che segnala come un gruppo di entità correlate di Apollo e Athene Annuity and Life Company detengano collettivamente 1.920.000 azioni preferenziali Serie F obbligatoriamente rimborsabili di Calamos Strategic Total Return Fund. Tale partecipazione rappresenta il 48,0% delle 4.000.000 MRPS in circolazione (secondo il rapporto certificato degli azionisti dell’emittente del 30 aprile 2025). Nessun soggetto dichiara poteri di voto o dispositivi in via esclusiva; ciascuno riporta zero poteri esclusivi e potere di voto e dispositivo condiviso su 1.920.000 azioni. La comunicazione afferma che i titoli sono stati acquisiti e sono detenuti nell’ordinario svolgimento dell’attività e non per cambiare o influenzare il controllo dell’emittente.

La presentación es una enmienda a un Schedule 13G que informa que un grupo de entidades relacionadas de Apollo y Athene Annuity and Life Company poseen colectivamente 1.920.000 acciones preferentes Serie F redimibles obligatoriamente de Calamos Strategic Total Return Fund. Esa participación representa el 48,0% de las 4.000.000 MRPS en circulación (según el informe certificado de accionistas del emisor de fecha 30 de abril de 2025). Ninguna persona informante reclama poder de voto o dispositivo exclusivo; cada una declara cero poder exclusivo y poder de voto y dispositivo compartido sobre 1.920.000 acciones. La presentación indica que los valores fueron adquiridos y se mantienen en el curso ordinario del negocio y no para cambiar o influir en el control del emisor.

이번 제출 서류는 Schedule 13G의 수정서로, 관련된 Apollo 계열사 그룹과 Athene Annuity and Life Company가 합쳐서 Calamos Strategic Total Return Fund의 1,920,000주 Series F 강제상환 우선주를 보유하고 있음을 보고합니다. 해당 보유분은 발행사 인증 주주보고서(2025년 4월 30일 기준)에 따른 유통 중인 4,000,000 MRPS의 48.0%에 해당합니다. 어떠한 보고인도 단독 의결권이나 처분권을 주장하지 않으며, 각 보고인은 단독 권한은 0이고 1,920,000주에 대해 공동 의결권 및 처분권을 보유한다고 보고합니다. 제출서류는 이 증권들이 영업 과정에서 취득·보유된 것이며 발행사의 지배권을 변경하거나 영향 미치려는 목적이 아님을 명시합니다.

Le dépôt est un amendement à un Schedule 13G déclarant qu’un groupe d’entités liées d’Apollo et Athene Annuity and Life Company détiennent collectivement 1 920 000 actions privilégiées Série F à rachat obligatoire du Calamos Strategic Total Return Fund. Cette participation représente 48,0 % des 4 000 000 MRPS en circulation (d’après le rapport certifié des actionnaires de l’émetteur en date du 30 avril 2025). Aucun déclarant ne revendique un pouvoir de vote ou de disposition exclusif ; chacun déclare zéro pouvoir exclusif et pouvoir de vote et de disposition partagé sur 1 920 000 actions. Le dépôt indique que les titres ont été acquis et sont détenus dans le cours normal des affaires et non dans le but de changer ou d’influencer le contrôle de l’émetteur.

Die Einreichung ist eine Änderung zu einem Schedule 13G, die meldet, dass eine Gruppe zusammengehöriger Apollo-Gesellschaften und die Athene Annuity and Life Company zusammen 1.920.000 Series F Mandatory Redeemable Preferred Shares des Calamos Strategic Total Return Fund halten. Diese Beteiligung entspricht 48,0% der 4.000.000 ausstehenden MRPS (laut dem zertifizierten Aktionärsbericht des Emittenten vom 30. April 2025). Keine meldende Person beansprucht alleiniges Stimm- oder Verfügungsrecht; jede gibt keine alleinigen Rechte und gemeinsame Stimm- und Verfügungsrechte für 1.920.000 Aktien an. In der Einreichung heißt es, die Wertpapiere seien im ordentlichen Geschäftsbetrieb erworben und gehalten worden und dienten nicht der Änderung oder Beeinflussung der Kontrolle über den Emittenten.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Apollo Management Holdings GP, LLC
Signature:/s/ William B. Kuesel
Name/Title:William B. Kuesel, Vice President
Date:08/14/2025
Athene Annuity and Life Company
Signature:Apollo Insurance Solutions Group LP
Name/Title:Investment Adviser
Date:08/14/2025
Signature:AISG GP Ltd.
Name/Title:General Partner
Date:08/14/2025
Signature:/s/ Angelo Lombardo
Name/Title:Angelo Lombardo, Authorized Signatory
Date:08/14/2025
Apollo Insurance Solutions Group LP
Signature:AISG GP Ltd.
Name/Title:General Partner
Date:08/14/2025
Signature:/s/ Angelo Lombardo
Name/Title:Angelo Lombardo, Authorized Signatory
Date:08/14/2025
AISG GP Ltd.
Signature:/s/ Angelo Lombardo
Name/Title:Angelo Lombardo, Authorized Signatory
Date:08/14/2025
Apollo Life Asset L.P.
Signature:Apollo Life Asset GP, LLC
Name/Title:General Partner
Date:08/14/2025
Signature:Apollo Capital Management, L.P.
Name/Title:Managing Member
Date:08/14/2025
Signature:Apollo Capital Management GP, LLC
Name/Title:General Partner
Date:08/14/2025
Signature:/s/ William Kuesel
Name/Title:William B. Kuesel, Vice President
Date:08/14/2025
Apollo Life Asset GP, LLC
Signature:Apollo Capital Management, L.P.
Name/Title:Managing Member
Date:08/14/2025
Signature:Apollo Capital Management GP, LLC
Name/Title:General Partner
Date:08/14/2025
Signature:/s/ William B. Kuesel
Name/Title:William B. Kuesel, Vice President
Date:08/14/2025
Apollo Capital Management, L.P.
Signature:Apollo Capital Management GP, LLC
Name/Title:General Partner
Date:08/14/2025
Signature:/s/ William B. Kuesel
Name/Title:William B. Kuesel, Vice President
Date:08/14/2025
Apollo Capital Management GP, LLC
Signature:/s/ William B. Kuesel
Name/Title:William B. Kuesel, Vice President
Date:08/14/2025
Apollo Management Holdings, L.P.
Signature:Apollo Management Holdings GP, LLC
Name/Title:General Partner
Date:08/14/2025
Signature:/s/ William B. Kuesel
Name/Title:William B. Kuesel, Vice President
Date:08/14/2025

FAQ

How many Series F MRPS does the Apollo/Athene group report owning in CSQ?

They report owning 1,920,000 Series F MRPS of Calamos Strategic Total Return Fund.

What percentage of the Series F class does the reported holding represent for CSQ?

The reported position represents 48.0% of the MRPS class based on 4,000,000 shares outstanding as of April 30, 2025.

Do any reporting persons claim sole voting or dispositive power over the shares in this CSQ filing?

No. All reporting persons report 0 sole voting power and 0 sole dispositive power, with shared power over 1,920,000 shares.

Was this filing presented as an attempt to influence control of Calamos Strategic Total Return Fund (CSQ)?

No. The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control of the issuer.

On what date and basis is the percent ownership calculated in this CSQ Schedule 13G/A?

The percent is based on 4,000,000 MRPS outstanding as of April 30, 2025, per the issuer's certified shareholder report filed June 27, 2025.
Calamos Strategic Total Return

NASDAQ:CSQ

CSQ Rankings

CSQ Latest News

CSQ Latest SEC Filings

CSQ Stock Data

2.98B
160.37M
0.16%
54.28%
0.01%
Asset Management
Financial Services
Link
United States
Naperville